创新药概念继续活跃 上海谊众20%涨停

Group 1 - The innovative drug concept remains active, with Shanghai Yizhong hitting a 20% limit up [1] - Nanxin Pharmaceutical increased by over 16% [1] - Dongcheng Pharmaceutical reached the limit up [1] Group 2 - Chenxin Pharmaceutical achieved a three-day consecutive board increase [1] - China Resources Double Crane and Asia-Pacific Pharmaceutical also saw significant gains [1]